AU2000255261A1 - Means for maintenance and/or correction of glucose concentration in blood - Google Patents

Means for maintenance and/or correction of glucose concentration in blood

Info

Publication number
AU2000255261A1
AU2000255261A1 AU2000255261A AU5526100A AU2000255261A1 AU 2000255261 A1 AU2000255261 A1 AU 2000255261A1 AU 2000255261 A AU2000255261 A AU 2000255261A AU 5526100 A AU5526100 A AU 5526100A AU 2000255261 A1 AU2000255261 A1 AU 2000255261A1
Authority
AU
Australia
Prior art keywords
blood
correction
maintenance
glucose concentration
polymeric matrix
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2000255261A
Other languages
English (en)
Inventor
Iouri Gennadievich Bobkov
Anatoliy Borisovich Davydov
Iouri Tikhonovich Kalinin
Gennadiy Ljvovich Khromov
Boris Ivanovich Leonov
Tatjana Igorevna Solodkaya
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ctp Cable Technology Procurement AG
Original Assignee
C T P CABLE TECHNOLOGY PROCURE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by C T P CABLE TECHNOLOGY PROCURE filed Critical C T P CABLE TECHNOLOGY PROCURE
Publication of AU2000255261A1 publication Critical patent/AU2000255261A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Sampling And Sample Adjustment (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
AU2000255261A 2000-05-26 2000-05-26 Means for maintenance and/or correction of glucose concentration in blood Abandoned AU2000255261A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2000/004826 WO2001091784A1 (fr) 2000-05-26 2000-05-26 Systeme de maintien et/ou de correction de la glycemie

Publications (1)

Publication Number Publication Date
AU2000255261A1 true AU2000255261A1 (en) 2001-12-11

Family

ID=8163961

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2000255261A Abandoned AU2000255261A1 (en) 2000-05-26 2000-05-26 Means for maintenance and/or correction of glucose concentration in blood

Country Status (6)

Country Link
US (1) US7259139B1 (fr)
EP (1) EP1289542B1 (fr)
AT (1) ATE401095T1 (fr)
AU (1) AU2000255261A1 (fr)
DE (1) DE60039540D1 (fr)
WO (1) WO2001091784A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007047922A2 (fr) 2005-10-19 2007-04-26 Smartcells, Inc. Conjugues polymeres-medicaments

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2504408B1 (fr) * 1981-04-24 1986-02-14 Couvreur Patrick Procede de preparation de particules submicroscopiques, particules ainsi obtenues et compositions pharmaceutiques les contenant
SU1011126A1 (ru) * 1981-07-14 1983-04-15 Всесоюзный научно-исследовательский и испытательный институт медицинской техники Средство дл лечени сахарного диабета
US4666704A (en) * 1985-05-24 1987-05-19 International Minerals & Chemical Corp. Controlled release delivery system for macromolecules
IE61651B1 (en) * 1990-07-04 1994-11-16 Zambon Spa Programmed release oral solid pharmaceutical dosage form
US6277410B1 (en) * 1992-10-08 2001-08-21 Supratek Pharma Inc. Copolymer compositions for oral delivery
JPH11510837A (ja) * 1995-07-28 1999-09-21 フォーカル，インコーポレイテッド 薬物送達のための制御された放出薬剤および組織処置薬剤としての使用のためのマルチブロック生分解性ヒドロゲル
SE505146C2 (sv) * 1995-10-19 1997-06-30 Biogram Ab Partiklar för fördröjd frisättning

Also Published As

Publication number Publication date
EP1289542A1 (fr) 2003-03-12
WO2001091784A1 (fr) 2001-12-06
ATE401095T1 (de) 2008-08-15
EP1289542B1 (fr) 2008-07-16
DE60039540D1 (de) 2008-08-28
US7259139B1 (en) 2007-08-21

Similar Documents

Publication Publication Date Title
AU2845599A (en) Pharmaceutical compositions and their use
WO2006052285A3 (fr) Nanoparticules et nanogels polymeres pour l'extraction et la liberation de composes
AR020633A1 (es) Parche cosmetico, farmaceutico o dermatologico.
WO2005044224A3 (fr) Systeme d'administration de medicament, faisant appel a des nanocoques polymeres
SI0973819T1 (sl) Neantigenski razvejeni polimerni konjugati
NO962088L (no) Preparat for in vivo-produksjon av terapeutiske produkter
CA2411277A1 (fr) Implant d'administration de neurotoxine
AU6559800A (en) Use of hyaluronic acid derivatives in pharmaceutical preparations and biomaterials for the prevention and treatment of cutaneous scars
WO2002064184A3 (fr) Procede de preparation d'un implant chirurgical
DE60028152D1 (de) Fester, stabiler und konzentrierter biologisch verdaulicher Komplex von Orthokieselsäure und Prozess zur dessen Herstellung
AU2001247968A1 (en) Use of asiatic acid or asiaticoside for treatment of cancer
AU1263400A (en) Stable aqueous insulin preparations without phenol and cresol
BRPI0414979A (pt) preparação sólida
DE59407457D1 (de) Blockierung der anlagerung von keimen an menschliche zellen
AU4104397A (en) Implant consisting of a carrier material containing medical substances and method to produce such an implant
HK1047707A1 (zh) (+)-曲馬朵、o-去甲曲馬朵或(+)-o-去甲曲馬朵、o-去甲-n-單-去甲-曲馬朵或(+)-o-去甲-n-單-去甲-曲馬朵治療尿失禁的用途
BR0009771A (pt) Utilização de derivados de bisindóis indigóides capazes de penetrarem na membrana de células
AU2668400A (en) Human antibiotic proteins
WO1999061014A3 (fr) Compositions et methodes utilisant de la r(-) fluoxetine et d'autres ingredients actifs
AU4765999A (en) Polyionic hydrogels based on xanthan and chitosan for stabilising and controlledrelease of vitamins
AU3163100A (en) Benzofuran-2-one
AU2000255261A1 (en) Means for maintenance and/or correction of glucose concentration in blood
ATE245974T1 (de) Pharmazeutische zusammensetzungen, bestimmt zur oralen verabreichung von phloroglucinol sowie deren herstellung
ATE226065T1 (de) Feste instant-release-darreichungsformen und verfahren zu ihrer herstellung
PL361732A1 (en) Use of a biological material containing three-dimensional scaffolds of hyaluronic acid derivatives for the preparation of implants in arthroscopy and kit for instruments for implanting said biological material by arthroscopy